| Titolo |
Pubblicato in |
Anno |
| A Comparative Study of Dietary Intake, Nutritional Status, and Frailty in Outpatients and Inpatients with Liver Cirrhosis |
NUTRIENTS |
2025 |
| Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Evolution of transplant oncology indications: a single-institution experience over 40 years |
UPDATES IN SURGERY |
2024 |
| Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis |
JOURNAL OF HEPATOLOGY |
2024 |
| Reply to: “Reevaluating myosteatosis criteria in cirrhosis: Fluid and gender considerations” |
JOURNAL OF HEPATOLOGY |
2024 |
| Reply to: “What references and what gold standard should be used to assess myosteatosis in chronic liver disease?” |
JOURNAL OF HEPATOLOGY |
2024 |
| Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis |
JOURNAL OF HEPATOLOGY |
2024 |
| Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial |
LIVER INTERNATIONAL |
2024 |
| Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study) |
HEPATOLOGY |
2024 |
| Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements |
HEPATOLOGY |
2024 |
| Sex disparities in acute-on-chronic liver failure: From admission to the intensive care unit to liver transplantation |
DIGESTIVE AND LIVER DISEASE |
2024 |
| Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis |
LIVER INTERNATIONAL |
2024 |
| Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver |
EXPERT OPINION ON EMERGING DRUGS |
2024 |
| Impaired nutritional status, frailty and inadequate dietary intake : a reality still underdiagnosed in liver cirrhosis patients |
DIGESTIVE AND LIVER DISEASE |
2024 |
| The crucial role of risk factors when dealing with hepatic Encephalopathy |
METABOLIC BRAIN DISEASE |
2024 |
| Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients |
Canadian Journal of Gastroenterology and Hepatology |
2023 |
| Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study |
FRONTIERS IN MEDICINE |
2023 |
| Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease |
HEPATOBILIARY SURGERY AND NUTRITION |
2023 |
| The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review |
NUTRIENTS |
2023 |
